Table 2.

Patient characteristics (N = 275)^a

		No. of patients	Percentage (%)
Sex	Female	190	69
	Male	85	31
Age, mean (range)		56 (24–87)
Hospital	1	22	7.9
	2	7	2.5
	3	48	17.3
	4	23	8.3
	5	19	7.2
	6	18	6.5
	7	43	15.5
	8	46	17.0
	9	49	17.7
WHO performance status	0	169	61.4
	1	83	30.3
	2	14	5.1
	3	5	1.8
	4	0	0
	unknown	4	1.4
Alcohol use	0 units/week	108	39.4
	1–4 units/week	96	34.7
	5–10 units/week	34	12.6
	11 or more units/week	29	10.5
	Unknown	8	2.9
Cancer diagnosis	Breast	127	46.2
	Lung	62	22.7
	Colorectal	27	9.7
	Urogenital	7	2.5
	Gynecological	11	4.0
	Lymphoma	17	6.1
	Other	24	8.8
Chemotherapy intent	Curative	59	21.7
	Adjuvant	115	41.5
	Palliative	76	27.8
	Neo-adjuvant	18	6.5
	Unknown	7	2.5
Emetogenicity of chemotherapy	High	101	37
	Moderate (anthracycline)	140	51
	Moderate (no anthracycline)	34	12
History of pregnancy emesis		43	15.6
History of motion sickness		41	14.9

^aThe two patients that dropped out before completing one study course were not included in the analyses